2024. Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer. Biomolecules and Biomedicine. 24, 2 (Mar. 2024), 230–237. DOI:https://doi.org/10.17305/bb.2023.9757.